At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Nov 6, 2026 at 17:00 ET
Ocugen filed a DEFA14A notice postponing its reconvened special meeting to December 22, 2026, to vote on a proposal to increase authorized common shares by 250 million. The meeting was originally convened on September 21, 2026, and has been adjourned multiple times. The board unanimously recommends a vote FOR the proposal.
- Special meeting reconvened on December 22, 2026 at 8:00 a.m. ET.
- Proposal 1: increase authorized common shares by 250,000,000 shares.
- Board unanimously recommends a vote FOR Proposal 1.
- New record date is October 30, 2026; 339,306,603 shares outstanding as of that date.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access